Romert L, Swedmark S, Jenssen D
Department of Genetic and Cellular Toxicology, Wallenberg Laboratory, Stockholm University, Sweden.
Carcinogenesis. 1991 May;12(5):847-53. doi: 10.1093/carcin/12.5.847.
The nitrosated form of cimetidine (Tagamet), nitrosocimetidine (NC), belongs to a group of nitrosoamidines in which the mutagenic and carcinogenic properties of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG) have been studied in detail. The common mechanism of action of these compounds is that nucleophilic atoms can attack their iminocarbon, thereby leading to the formation of alkyldiazohydroxide and, subsequently of an alkylating and mutagenic diazonium ion. A competitive, non-mutagenic pathway involves denitrosation, which is strongly dependent on pH and can be enhanced by glutathione transferase. The influence of different thiols (e.g. glutathione and the L- and D-forms of N-acetylcysteine (L-NAC and D-NAC respectively] at different extra- and intracellular concentrations on the mutagenicity of these nitrosoamidines in V79 cells has been studied in the present investigation. The results demonstrate that the mutagenicity of MNNG and ENNG is highly dependent on where their reaction with thiols takes place. Thus, an increase in the intracellular glutathione level in combination with treatment with MNNG (or ENNG) in thiol-free medium elevated the mutagenicity, whereas treatment with thiols in the medium reduced mutagenicity. The mutagenicity of NC was, on the other hand, only slightly affected by increasing extra- or intracellular thiol levels. The dependence of NC-induced mutagenicity on thiols was indicated, however, by the finding that depletion of intracellular glutathione reduced this mutagenicity almost completely. The effects of treatments with thiols alone or in combination with glutathione transferases suggest that, under our assay conditions (e.g. physiological pH and thiol levels, in combination with low levels of the nitrosoamidines), no denitrosation occurs. On the contrary, our results indicate that intracellular thiols, and possibly glutathione transferases, potentiate the production of mutagenic species from these nitrosamidines.
西咪替丁(泰胃美)的亚硝化形式,即亚硝基西咪替丁(NC),属于一类亚硝基脒,其中N-甲基-N'-硝基-N-亚硝基胍(MNNG)和N-乙基-N'-硝基-N-亚硝基胍(ENNG)的致突变性和致癌性已得到详细研究。这些化合物的共同作用机制是亲核原子可攻击其亚氨基碳,从而导致烷基重氮氢氧化物的形成,随后形成烷基化和致突变的重氮离子。一条竞争性的、非致突变途径涉及脱亚硝化作用,这强烈依赖于pH值,并且可被谷胱甘肽转移酶增强。在本研究中,已研究了不同细胞外和细胞内浓度的不同硫醇(例如谷胱甘肽以及N-乙酰半胱氨酸的L型和D型(分别为L-NAC和D-NAC))对这些亚硝基脒在V79细胞中的致突变性的影响。结果表明,MNNG和ENNG的致突变性高度依赖于它们与硫醇反应发生的位置。因此,在无硫醇培养基中,细胞内谷胱甘肽水平的增加与MNNG(或ENNG)处理相结合会提高致突变性,而在培养基中用硫醇处理则会降低致突变性。另一方面,细胞外或细胞内硫醇水平的增加对NC的致突变性影响很小。然而,细胞内谷胱甘肽的消耗几乎完全降低了这种致突变性,这一发现表明NC诱导的致突变性对硫醇有依赖性。单独用硫醇或与谷胱甘肽转移酶联合处理的效果表明,在我们的检测条件下(例如生理pH值和硫醇水平,以及低水平的亚硝基脒),不会发生脱亚硝化作用。相反,我们的结果表明,细胞内硫醇以及可能的谷胱甘肽转移酶会增强这些亚硝基脒产生致突变物种的能力。